Skip to main content
Xlife Sciences AG logo

Xlife Sciences AG — Investor Relations & Filings

Ticker · XLS ISIN · CH0461929603 LEI · 984500AH590BE88BB517 SW Professional, scientific and technical activities
Open in API
Filings indexed 287 across all filing types
Latest filing 2021-10-14 Director's Dealing
Country CH Switzerland
Listing SW XLS

About Xlife Sciences AG

https://www.xlifesciences.ch/en/home

Xlife Sciences AG is a life sciences company that specializes in the value development and commercialization of early-stage research projects. The company identifies promising technologies from universities and other research institutions, acting as an incubator and accelerator to bridge the gap between academic research and healthcare markets. Its operations are focused on four core areas: technology platforms, biotechnologies and therapies, medical technology (health technology), and the application of artificial intelligence in life sciences and digital health. The primary objective is to develop solutions that address high unmet medical needs and improve quality of life.

Recent filings

Filing Released Lang Actions
DGAP-DD: Xlife Sciences AG english
Director's Dealing Classification · 1% confidence The document is explicitly titled 'Directors’ Dealings' and contains a section header 'DGAP-DD: Xlife Sciences AG english' followed by 'Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them'. Section 4 details the 'transaction(s)', including the nature ('Acquisition'), price, volume, date, and place. This content directly matches the definition for Director's Dealing reports.
2021-10-14 English
DGAP-DD: Xlife Sciences AG english
Director's Dealing Classification · 1% confidence The document explicitly contains the header "Directors’ Dealings" and the title "Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them". Section 4 details the 'Nature of the transaction' as 'Acquisition' by an individual identified as a 'Member of the managing body'. This content directly corresponds to the definition of Director's Dealing reports.
2021-10-13 English
DGAP-DD: Xlife Sciences AG english
Director's Dealing Classification · 1% confidence The document is explicitly titled 'Directors’ Dealings' and contains a section detailing 'Notification and public disclosure of transactions by persons discharging managerial responsibilities'. It lists the name of an individual (Oliver R. Baumann), their position ('Member of the managing body'), and details of a transaction ('Acquisition' of shares) including price, volume, and date. This perfectly matches the definition for Director's Dealing.
2021-10-13 English
DGAP-DD: Xlife Sciences AG english
Director's Dealing Classification · 1% confidence The document explicitly contains the header "Directors’ Dealings" and details transactions made by a person discharging managerial responsibilities (Oliver R. Baumann, Member of the managing body). This directly corresponds to the definition of Director's Dealing, which is classified as code DIRS.
2021-10-13 English
DGAP-DD: Xlife Sciences AG english
Director's Dealing Classification · 1% confidence The document is explicitly titled 'Directors’ Dealings' and contains a section header 'Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them'. It details a transaction (Acquisition) by an individual named Oliver R. Baumann, who is a 'Member of the managing body' of Xlife Sciences AG. This content directly matches the definition for Director's Dealing reports.
2021-10-13 English
DGAP-DD: Xlife Sciences AG english
Director's Dealing Classification · 1% confidence The document is explicitly titled 'Directors’ Dealings' and contains a section header 'Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them'. It details a transaction (Acquisition) by an individual named Oliver R. Baumann, who is a 'Member of the managing body' of Xlife Sciences AG, including the date, price, volume, and instrument details. This directly corresponds to the definition of Director's Dealing.
2021-10-13 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.